For the Inventor, By the Inventor

Enter assignee name

Louisville, CO, United States of America

Globeimmune, Inc.

USPTO Granted Patents = 58

% Expired Patents = 17.2

CIPO Patents = 2

EPO Patents = 15

Trademarks = 3

Forward Citations = 539

Loading Chart...

Loading Chart...

24 inventors (with patents filed for the assignee):

Alex Franzusoff (29 out of 38 patents)

Thomas H King (26 out of 26 patents)

Zhimin Guo (21 out of 21 patents)

4. David Apelian (21 out of 21 patents)

5. Jeffrey Schlom (14 out of 85 patents)

6. Donald Bellgrau (14 out of 21 patents)

7. Richard C Duke (11 out of 17 patents)

8. Claire Coeshott (8 out of 10 patents)

9. Claudia M Palena (7 out of 13 patents)

10. Aurelia Haller (7 out of 15 patents)

11. Yingnian Lu (4 out of 4 patents)

12. Kwong-Yok Tsang (3 out of 25 patents)

13. James W Hodge (3 out of 14 patents)

14. Cara C Wilson (3 out of 3 patents)

15. Heinrich Röder (2 out of 41 patents)

Core Competencies:

Immunotherapy

Yeast-Based Vaccines

Cancer Treatment

Viral Infections

Hepatitis B

Hepatitis C

Human Immunodeficiency Virus

Tuberculosis

Mass-Spectral Method

Chronic Hepatitis

Yeast-Antigen Compositions

Combination Immunotherapy

58 patents: Sort by Forward Citations

1. 12128078 - Lysates of recombinant yeast for inducing cellular immune responses (2024-10-29),

2. 12076382 - Combination immunotherapy compositions against cancer and methods (2024-09-03),

3. 11944673 - Yeast-brachyury immunotherapeutic compositions (2024-04-02),

4. 11938175 - Yeast-brachyury immunotherapeutic compositions (2024-03-26),

5. 11596675 - Combination immunotherapy compositions against cancer and methods (2023-03-07),

6. 11304996 - Yeast-based immunotherapy and type I interferon sensitivity (2022-04-19),

7. 11065318 - Yeast-MUC1 immunotherapeutic compositions and uses thereof (2021-07-20),

8. 11065313 - Modified yeast-brachyury immunotherapeutic compositions (2021-07-20),

9. 10874729 - Combination immunotherapy compositions against cancer and methods (2020-12-29),

10. 10849971 - Compositions and methods for the treatment or prevention of human immunodeficiency virus infection (2020-12-01),

11. 10799567 - Yeast-based immunotherapy and type I interferon sensitivity (2020-10-13),

12. 10722567 - Compositions and methods for the treatment or prevention of tuberculosis (2020-07-28),

13. 10593529 - Mass-spectral method for selection, and de-selection, of cancer patients for treatment with immune response generating therapies (2020-03-17),

14. 10507235 - Yeast-based immunotherapy for Chordoma (2019-12-17),

15. 10441650 - Compositions and methods for the treatment or prevention of hepatitis B virus infection (2019-10-15),

Company Overview

Globeimmune, Inc. is a biotechnology company based in Louisville, Colorado, specializing in the development of innovative immunotherapy compositions. The company focuses on harnessing yeast-based vaccines to address a range of serious health conditions, including various cancers and viral infections such as Hepatitis B, Hepatitis C, and Human Immunodeficiency Virus (HIV). Globeimmune's research aims to enhance immune responses and improve treatment outcomes for patients facing challenging diseases, including tuberculosis.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

58 Patents

#4 in Louisville, CO

#122 in Colorado

#6,157 in US

#12,395 in the World

Louisville, CO, United States of America

Globeimmune, Inc.

Forward Citations = 539

24 inventors:

Alex Franzusoff (29 out of 38 patents)

Thomas H King (26 out of 26 patents)

Zhimin Guo (21 out of 21 patents)

4. David Apelian (21 out of 21 patents)

5. Jeffrey Schlom (14 out of 85 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Globeimmune, Inc.. Retrieved from https://idiyas.com/company/globeimmune

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…